SMOFLIPID 200 mg/ml, emulsion for infusion 12 bags of 500 ml
Active ingredients: HUILE D'OLIVE RAFFINÉE, HUILE DE POISSON RICHE EN ACIDES OMÉGA-3, HUILE DE SOJA RAFFINÉE, TRIGLYCÉRIDES À CHAÎNE MOYENNE
Commercialized according to BDPM
Emulsion for infusion12 bags of 500 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SMOFLIPID 200 mg/ml, émulsion pour perfusion
- Pharmaceutical form
- émulsion pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 12 poche(s) plastique Biofine de 500 ml suremballée(s)/surpochée(s)
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Oct 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60650173CIP73003817CIP133400930038178Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HUILE DE SOJA RAFFINÉEémulsion | 60 g · 1000 ml d'émulsion pour perfusion | SA |
| TRIGLYCÉRIDES À CHAÎNE MOYENNEémulsion | 60 g · 1000 ml d'émulsion pour perfusion | SA |
| HUILE D'OLIVE RAFFINÉEémulsion | 50 g · 1000 ml d'émulsion pour perfusion | SA |
| HUILE DE POISSON RICHE EN ACIDES OMÉGA-3émulsion | 30 g · 1000 ml d'émulsion pour perfusion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 10 bags of 100 mlCommercialized according to BDPM
- 10 bags of 250 mlCommercialized according to BDPM
- 6 bags of 1000 mlCommercialized according to BDPM
- bottle, 250 mlCommercialized according to BDPM
- bottle, 500 mlCommercialized according to BDPM
- 10 bottles of 100 mlCommercialized according to BDPM
- 10 bottles of 250 mlCommercialized according to BDPM
- 10 bottles of 500 mlCommercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.